|
|||||
|
|
Comparative effectiveness of sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors on liver function in patients with type 2 diabetes in Japan: A real-world data analysis |
|
| Authors: | Hirokazu Takahashi MD Keiko Asakawa PhD Yoshinori Kosakai MSc Takumi Lee BPharm Mitsuhiro Rokuda PhD |
| Affiliation: | 1. Liver Center, Saga University Hospital, Saga, Japan;2. Astellas Pharma Inc., Tokyo, Japan |
| Abstract: | |
| Keywords: | DPP4 inhibitor fatty disease liver real-world evidence SGLT2 inhibitor type 2 diabetes |